HighVista Strategies’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,101
Closed -$3.25M 143
2024
Q3
$3.25M Buy
+10,101
New +$3.3M 1.12% 23
2019
Q3
Sell
-2,800
Closed -$516K 128
2019
Q2
$516K Buy
+2,800
New +$501K 0.26% 63
2018
Q1
Sell
-2,100
Closed -$365K 168
2017
Q4
$365K Sell
2,100
-600
-22% -$106K 0.1% 154
2017
Q3
$503K Sell
2,700
-700
-21% -$124K 0.11% 127
2017
Q2
$586K Sell
3,400
-600
-15% -$97.6K 0.13% 109
2017
Q1
$656K Sell
4,000
-1,600
-29% -$266K 0.15% 133
2016
Q4
$819K Sell
5,600
-1,700
-23% -$256K 0.16% 146
2016
Q3
$1.22M Sell
7,300
-900
-11% -$152K 0.23% 132
2016
Q2
$1.25M Sell
8,200
-2,300
-22% -$358K 0.24% 106
2016
Q1
$1.57M Buy
10,500
+1,187
+13% +$176K 0.3% 82
2015
Q4
$1.51M Buy
9,313
+7,840
+532% +$1.23M 0.28% 85
2015
Q3
$204K Buy
+1,473
New +$232K 0.04% 176
2015
Q2
Sell
-1,346
Closed -$215K 166
2015
Q1
$215K Buy
+1,346
New +$212K 0.03% 169
2014
Q4
Sell
-1,682
Closed -$236K 151
2014
Q3
$236K Buy
+1,682
New +$220K 0.03% 139
2014
Q2
Sell
-1,926
Closed -$213K 151
2014
Q1
$213K Buy
+1,926
New +$234K 0.03% 140

Other funds holding AMGN

HighVista Strategies's AMGN Position: Q4 2024 in Review

HighVista Strategies sold out of Amgen (AMGN) in Q4 2024, closing a stake of 10,101 shares — an estimated $3.25M sold.

HighVista Strategies first reported a position in AMGN in Q1 2014 and held it in 15 quarters. The position peaked at $3.25M in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • HighVista Strategies reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • HighVista Strategies sold 10,101 Amgen shares in Q4 2024, an estimated $3.25M.
  • HighVista Strategies first reported a position in Amgen in Q1 2014 and held it in 15 quarters.
  • HighVista Strategies's Amgen position peaked at $3.25M in Q3 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on HighVista Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.